Elke A. Jarboe
No Rating Available
(Learn About Our Rating System)

Elke A. Jarboe, MD

Languages spoken: English

  • Dr. Jarboe is a staff pathologist at ARUP and an associate professor of pathology at the University of Utah School of Medicine. She received her MD from and completed her anatomic pathology residency training at the University of Colorado School of Medicine. Subsequently, she completed fellowships in women’s and perinatal pathology and cytopathology at Brigham and Women's Hospital in Boston. Dr. Jarboe is a member of several professional societies, including the United States and Canadian Academy of Pathology, American Association for Cancer Research, American Society for Clinical Pathology, and College of American Pathologists.

    Dr. Jarboe's primary subspecialty and research interest is in gynecologic pathology.

    Specialties

    • Pathology, Anatomical

    Board Certification

    American Board of Pathology (Anatomic)
    American Board of Pathology (Sub: Cytopathology)
    National Board of Medical Examiners

  • Dr. Jarboe is a staff pathologist at ARUP and an associate professor of pathology at the University of Utah School of Medicine. She received her MD from and completed her anatomic pathology residency training at the University of Colorado School of Medicine. Subsequently, she completed fellowships in women’s and perinatal pathology and cytopathology at Brigham and Women's Hospital in Boston. Dr. Jarboe is a member of several professional societies, including the United States and Canadian Academy of Pathology, American Association for Cancer Research, American Society for Clinical Pathology, and College of American Pathologists.

    Dr. Jarboe's primary subspecialty and research interest is in gynecologic pathology.

    Board Certification and Academic Information

    Academic Departments Pathology -Primary
    Obstetrics & Gynecology -Adjunct
    Academic Divisions Gynecological Oncology
    Board Certification
    American Board of Pathology (Anatomic)
    American Board of Pathology (Sub: Cytopathology)
    National Board of Medical Examiners

    Education history

    Fellowship Cytopathology - Brigham and Women's Hospital Fellow
    Division of Women's and Perinatal Pathology - Brigham and Women's Hospital Fellow
    Residency Pathology - University of Colorado School of Medicine Resident
    Pathology - University of Colorado School of Medicine Intern
    Fellowship University of Colorado School of Medicine Post-Sophomore Fellow
    Medicine - University of Colorado School of Medicine M.D.
    Graduate Training Microbiology - Colorado State University Master's
    Microbiology - Colorado State University B.S.

    Selected Publications

    Journal Article

    1. Blanchard Z, Rush CM, Arnesen S, Vahrenkamp JM, Rodriguez AC, Jarboe EA, Brown C, Chang MEK, Flory MR, Mohammed H, Modzelewska K, Lum DH, Gertz J (2022). Allele-Specific Gene Regulation, Phenotypes, and Therapeutic Vulnerabilities in Estrogen Receptor Alpha-Mutant Endometrial Cancer. Mol Cancer Res, 21(10), 1023-1036. (Read full article)
    2. Barnard ME, Meeks H, Jarboe EA, Albro J, Camp NJ, Doherty JA (2022). Familial risk of epithelial ovarian cancer after accounting for gynaecological surgery: a population-based study. J Med Genet, 60(2), 119-127. (Read full article)
    3. Harris KL, Maurer KA, Jarboe E, Werner TL, Gaffney D (2019). LVSI positive and NX in early endometrial cancer: Surgical restaging (and no further treatment if N0), or adjuvant ERT? Gynecol Oncol, 156(1), 243-250. (Read full article)
    4. Vahrenkamp JM, Szczotka K, Dodson MK, Jarboe EA, Soisson AP, Gertz J (2019). FFPEcap-seq: a method for sequencing capped RNAs in formalin-fixed paraffin-embedded samples. Genome Res, 29(11), 1826-1835. (Read full article)
    5. Dillon C, Rezvani M, McLean H, Adelman M, Dassel M, Jarboe E, Jant-Amsbury M, Payne A (2019). A tissue preparation to characterize uterine fibroid tissue properties for thermal therapies. Med Phys, 46(8), 3344-3355. (Read full article)
    6. Baniak N, Fadare O, Kbel M, DeCoteau J, Parkash V, Hecht JL, Hanley KZ, Gwin K, Zheng W, Quick CM, Jarboe EA, Liang SX, Kinloch M (2018). Targeted Molecular and Immunohistochemical Analyses of Endometrial Clear Cell Carcinoma Show that POLE Mutations and DNA Mismatch Repair Protein Deficiencies Are Uncommon. Am J Surg Pathol, 43(4), 531-537. (Read full article)
    7. Fadare O, Desouki MM, Gwin K, Hanley KZ, Jarboe EA, Liang SX, Quick CM, Rawish KR, Roma AA, Zheng W, Hecht JL, Parkash V, Osunkoya AO (2017). Clear Cell Renal Cell Carcinoma Metastatic to the Gynecologic Tract: A Clinicopathologic Analysis of 17 Cases. Int J Gynecol Pathol, 37(6), 525-535. (Read full article)
    8. Vahrenkamp JM, Yang CH, Rodriguez AC, Almomen A, Berrett KC, Trujillo AN, Guillen KP, Welm BE, Jarboe EA, Janat-Amsbury MM, Gertz J (2017). Clinical and Genomic Crosstalk between Glucocorticoid Receptor and Estrogen Receptor α In Endometrial Cancer. Cell Rep, 22(11), 2995-3005. (Read full article)
    9. Taurin S, Yang CH, Reyes M, Cho S, Coombs DM, Jarboe EA, Werner TL, Peterson CM, Jant-Amsbury MM (2017). Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model. Int J Gynecol Cancer, 28(1), 152-160. (Read full article)
    10. Folkins AK, Jarboe EA, Saleemuddin A, Lee Y, Callahan MJ, Drapkin R, Garber JE, Muto MG, Tworoger S, Crum CP (2008). A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations. Gynecol Oncol, 109(2), 168-73. (Read full article)
    11. Jarboe EA, Folkins AK, Nucci MR, Kindelberger D, Drapkin R, Miron A, Lee Y, Crum CP (2008). Serous Carcinogenesis in the Fallopian Tube (SCAT): A Descriptive Classification. Int J Gynecol Pathol, 27(1), 1-9.
    12. Jarboe EA, Thompson LC, Heinz D, McGregor JA, Shroyer KR (2004). Telomerase and human papillomavirus as diagnostic adjuncts for cervical dysplasia and carcinoma. Hum Pathol, 35(4), 396-402. (Read full article)

    Review

    1. Salah HT, Stivers NS, Jarboe EA, Dodson MK, Ward MB (2020). Extraskeletal Myxoid Chondrosarcoma of the Vulva Confirmed by EWSR1 FISH: A Case Report and Review of the Literature. [Review]. Int J Gynecol Pathol, 40(5), 470-476. (Read full article)
    2. Jarboe EA, Folkins AK, Drapkin R, Ince TA, Agoston ES, Crum CP (2008). Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective. [Review]. Histopathology, 53(2), 127-38. (Read full article)

    Book Chapter

    1. Jarboe EA, Folkins A, Callahan MJ, Crum CP (2008). Pathology of BRCA-Associated Ovarian Cancers, Including Occult Cancers. In Lu KH (Ed.), Hereditary Gynecologic Cancer: Risk, Prevention, and Management (pp. 29-44). Informa Healthcare.

    Letter

    1. Fadare O, Roma AA, Desouki MM, Gwin K, Hanley KZ, Jarboe EA, Liang SX, Quick CM, Zheng W, Hecht JL, Parkash V, Wang XJ (2017). The significance of L1CAM expression in clear cell carcinoma of the endometrium. [Letter to the editor]. Histopathology, 72(3), 532-538. (Read full article)